IDS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.864400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.318400E-01
Normal-vs-Stage2
8.857200E-01
Normal-vs-Stage3
9.597500E-02
Normal-vs-Stage4
4.366400E-01
Stage1-vs-Stage2
3.438800E-01
Stage1-vs-Stage3
1.635430E-01
Stage1-vs-Stage4
8.554200E-01
Stage2-vs-Stage3
1.915760E-01
Stage2-vs-Stage4
1.048630E-01
Stage3-vs-Stage4
9.813900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.935400E-01
Normal-vs-AfricanAmerican
8.021600E-01
Normal-vs-Asian
9.408000E-01
Caucasian-vs-AfricanAmerican
9.437200E-01
Caucasian-vs-Asian
7.126400E-01
AfricanAmerican-vs-Asian
7.110400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.081000E-01
Normal-vs-Female
8.593800E-01
Male-vs-Female
7.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.631400E-01
Normal-vs-Age(41-60Yrs)
5.084000E-01
Normal-vs-Age(61-80Yrs)
8.470000E-01
Normal-vs-Age(81-100Yrs)
1.074830E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.303600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.318200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.435800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.524600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.48549999999348E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.189700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.940600E-01
Normal-vs-Daily Drinker
9.466200E-01
Normal-vs-Weekly Drinker
4.329200E-01
Normal-vs-Occasional Drinker
4.211800E-01
Normal-vs-Social Drinker
7.650600E-01
Non Drinker-vs-Daily Drinker
1.707780E-01
Non Drinker-vs-Weekly Drinker
6.967000E-01
Non Drinker-vs-Occasional Drinker
8.836500E-03
Non Drinker-vs-Social Drinker
1.980600E-01
Daily Drinker-vs-Weekly Drinker
2.876200E-01
Daily Drinker-vs-Occasional Drinker
1.192970E-01
Daily Drinker-vs-Social Drinker
5.945200E-01
Weekly Drinker-vs-Occasional Drinker
1.562340E-02
Weekly Drinker-vs-Social Drinker
2.552400E-01
Occasional Drinker-vs-Social Drinker
5.475800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.438400E-01
Normal-vs-Grade 2
1.317050E-01
Normal-vs-Grade 3
1.543160E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.695800E-01
Grade 1-vs-Grade 3
1.163770E-01
Grade 1-vs-Grade 4
3.438400E-01
Grade 2-vs-Grade 3
5.330600E-01
Grade 2-vs-Grade 4
1.317050E-01
Grade 3-vs-Grade 4
1.543160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.548800E-01
Normal-vs-NonDiabetic
8.339200E-01
Diabetic-vs-NonDiabetic
1.390570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.341200E-01
Normal-vs-NoPancreatitis
8.929200E-01
Pancreatitis-vs-NoPancreatitis
1.090020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.480000E-01
Normal-vs-N1
8.855800E-01
N0-vs-N1
1.259610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.311800E-01
Normal-vs-TP53-NonMutant
3.272000E-01
TP53-Mutant-vs-TP53-NonMutant
3.637400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
